Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Letter

Luminal B breast tumors are not HER2 positive

Rohit Bhargava email and David J Dabbs email

Department of Pathology, Magee-Womens Hospital of University of Pittsburgh Medical Center, Halket Street, Pittsburgh, Pennsylvania 15213, USA

author email corresponding author email

Breast Cancer Research 2008, 10:404doi:10.1186/bcr2134

Published: 26 September 2008


See related research article by Tamimi et al., http://breast-cancer-research.com/content/10/4/R67 and related letter by Tamimi et al., http://breast-cancer-research.com/content/10/5/405

First paragraph (this article has no abstract)

We read with interest the article by Tamimi and coworkers recently published in this journal [1]. The authors compared the molecular subtypes of invasive carcinoma versus ductal carcinoma in situ and found significant differences, as expected [1]. However, we have some concerns regarding the criteria used in the study.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.